Correlations Between Early MRI Parameters and Long-term Clinical Outcomes in Phase 3 and Open-label Extension Studies of Ozanimod in Relapsing Multiple Sclerosis (P5-3.010)

Douglas L Arnold,Diego Silva,John Deluca,Bruce A C Cree,Chahin Pachai,Amit Bar-Or,Leorah Freeman,Jon V Riolo,Hans-Peter Hartung,Xavier Montalbán,Lawrence Steinman,Jeffrey A Cohen,Chun-Yen Cheng

doi:10.1212/wnl.0000000000202335

Correlations Between Early MRI Parameters and Long-term Clinical Outcomes in Phase 3 and Open-label Extension Studies of Ozanimod in Relapsing Multiple Sclerosis (P5-3.010)

Douglas L Arnold, Diego Silva + Show 11 more

https://doi.org/10.1212/wnl.0000000000202335

Copy DOI

Journal: Neurology

Publication Date: Apr 25, 2023

Affiliation: NeuroRx Research (Canada), McGill University, Bristol-Myers Squibb (United States), Kessler Foundation, Rutgers, The State University of New Jersey, University of California, San Francisco, University of Pennsylvania, Heinrich Heine University Düsseldorf, University of Sydney, Medical University of Vienna, Palacký University, Olomouc, Vall d'Hebron Hospital Universitari, Stanford University, Stanford Medicine, Cleveland Clinic

#Received Research Support #Scientific Advisory + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Correlations Between Early MRI Parameters and Long-term Clinical Outcomes in Phase 3 and Open-label Extension Studies of Ozanimod in Relapsing Multiple Sclerosis (P5-3.010)

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Neurology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.